

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 9.40081338 |
| 2 | intestinal epithelial cell development (GO:0060576) | 7.46471121 |
| 3 | vitamin A metabolic process (GO:0006776) | 7.00029775 |
| 4 | intestinal cholesterol absorption (GO:0030299) | 6.97702400 |
| 5 | angiotensin maturation (GO:0002003) | 6.83016584 |
| 6 | hormone catabolic process (GO:0042447) | 5.86541280 |
| 7 | daunorubicin metabolic process (GO:0044597) | 5.67004613 |
| 8 | polyketide metabolic process (GO:0030638) | 5.67004613 |
| 9 | doxorubicin metabolic process (GO:0044598) | 5.67004613 |
| 10 | monoubiquitinated protein deubiquitination (GO:0035520) | 5.64317439 |
| 11 | transepithelial transport (GO:0070633) | 5.44711814 |
| 12 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.27355731 |
| 13 | flavonoid metabolic process (GO:0009812) | 5.04653138 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 5.03459211 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 5.03459211 |
| 16 | tryptophan catabolic process (GO:0006569) | 5.03459211 |
| 17 | actin filament depolymerization (GO:0030042) | 5.02230044 |
| 18 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.98502441 |
| 19 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.95408062 |
| 20 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.94852508 |
| 21 | indolalkylamine metabolic process (GO:0006586) | 4.73967206 |
| 22 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.69541194 |
| 23 | cellular response to ethanol (GO:0071361) | 4.69308180 |
| 24 | digestive system process (GO:0022600) | 4.54492874 |
| 25 | cytidine deamination (GO:0009972) | 4.51554624 |
| 26 | cytidine metabolic process (GO:0046087) | 4.51554624 |
| 27 | cytidine catabolic process (GO:0006216) | 4.51554624 |
| 28 | interkinetic nuclear migration (GO:0022027) | 4.50126412 |
| 29 | regulation of pigment cell differentiation (GO:0050932) | 4.46323326 |
| 30 | phospholipid translocation (GO:0045332) | 4.43822607 |
| 31 | lipid translocation (GO:0034204) | 4.43822607 |
| 32 | kynurenine metabolic process (GO:0070189) | 4.42582552 |
| 33 | trophectodermal cell differentiation (GO:0001829) | 4.42380054 |
| 34 | regulation of bile acid biosynthetic process (GO:0070857) | 4.39963178 |
| 35 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.38537391 |
| 36 | tryptophan metabolic process (GO:0006568) | 4.37964406 |
| 37 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.30035561 |
| 38 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.30035561 |
| 39 | sulfur compound transport (GO:0072348) | 4.29214674 |
| 40 | positive regulation of developmental pigmentation (GO:0048087) | 4.28147536 |
| 41 | protein K48-linked deubiquitination (GO:0071108) | 4.24922502 |
| 42 | modified amino acid transport (GO:0072337) | 4.22985751 |
| 43 | negative regulation of epidermis development (GO:0045683) | 4.22446187 |
| 44 | phenol-containing compound catabolic process (GO:0019336) | 4.22130893 |
| 45 | GDP-mannose metabolic process (GO:0019673) | 4.17155551 |
| 46 | regulation of hippo signaling (GO:0035330) | 4.17148421 |
| 47 | * UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.12788093 |
| 48 | bile acid and bile salt transport (GO:0015721) | 4.12326576 |
| 49 | sulfate transport (GO:0008272) | 4.10900728 |
| 50 | signal peptide processing (GO:0006465) | 4.06306219 |
| 51 | sulfate transmembrane transport (GO:1902358) | 4.04603193 |
| 52 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.04117211 |
| 53 | response to hepatocyte growth factor (GO:0035728) | 4.04117211 |
| 54 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.96660637 |
| 55 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.94690812 |
| 56 | epithelial structure maintenance (GO:0010669) | 3.92621061 |
| 57 | thyroid hormone metabolic process (GO:0042403) | 3.90810054 |
| 58 | hypotonic response (GO:0006971) | 3.89756235 |
| 59 | primary alcohol catabolic process (GO:0034310) | 3.88815155 |
| 60 | somite rostral/caudal axis specification (GO:0032525) | 3.82548971 |
| 61 | O-glycan processing (GO:0016266) | 3.82094408 |
| 62 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.79086830 |
| 63 | regulation of establishment of cell polarity (GO:2000114) | 3.78374294 |
| 64 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.75476348 |
| 65 | snRNA transcription (GO:0009301) | 3.75392292 |
| 66 | protein K11-linked deubiquitination (GO:0035871) | 3.70503977 |
| 67 | sulfur amino acid catabolic process (GO:0000098) | 3.68279295 |
| 68 | notochord development (GO:0030903) | 3.67567901 |
| 69 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.66381616 |
| 70 | neural tube formation (GO:0001841) | 3.65224772 |
| 71 | hepatocyte apoptotic process (GO:0097284) | 3.62604917 |
| 72 | drug catabolic process (GO:0042737) | 3.59256574 |
| 73 | adhesion of symbiont to host cell (GO:0044650) | 3.58718909 |
| 74 | virion attachment to host cell (GO:0019062) | 3.58718909 |
| 75 | negative regulation of complement activation (GO:0045916) | 3.54560471 |
| 76 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.53255546 |
| 77 | establishment of protein localization to Golgi (GO:0072600) | 3.51656722 |
| 78 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.50727827 |
| 79 | maintenance of protein location in nucleus (GO:0051457) | 3.49343600 |
| 80 | histone H3-K4 trimethylation (GO:0080182) | 3.47411790 |
| 81 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.46259996 |
| 82 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.45536985 |
| 83 | NAD biosynthetic process (GO:0009435) | 3.43947429 |
| 84 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.41457086 |
| 85 | digestion (GO:0007586) | 3.38997877 |
| 86 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.36106617 |
| 87 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.35686620 |
| 88 | protein localization to kinetochore (GO:0034501) | 3.34683175 |
| 89 | photoreceptor cell maintenance (GO:0045494) | 3.34331595 |
| 90 | sulfation (GO:0051923) | 3.33729375 |
| 91 | heterochromatin organization (GO:0070828) | 3.32857127 |
| 92 | muscle organ morphogenesis (GO:0048644) | 3.32681249 |
| 93 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.32164377 |
| 94 | negative regulation of protein activation cascade (GO:2000258) | 3.31952954 |
| 95 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.29427960 |
| 96 | regulation of gene silencing by miRNA (GO:0060964) | 3.29427960 |
| 97 | regulation of gene silencing by RNA (GO:0060966) | 3.29427960 |
| 98 | regulation of response to osmotic stress (GO:0047484) | 3.28755508 |
| 99 | nucleoside transmembrane transport (GO:1901642) | 3.27156559 |
| 100 | tachykinin receptor signaling pathway (GO:0007217) | 3.26808929 |
| 101 | indole-containing compound metabolic process (GO:0042430) | 3.25098951 |
| 102 | epoxygenase P450 pathway (GO:0019373) | 3.24612132 |
| 103 | protein K63-linked deubiquitination (GO:0070536) | 3.22359295 |
| 104 | regulation of sarcomere organization (GO:0060297) | 3.19815113 |
| 105 | nucleoside transport (GO:0015858) | 3.17000789 |
| 106 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.15970613 |
| 107 | regulation of viral release from host cell (GO:1902186) | 3.15600939 |
| 108 | drug metabolic process (GO:0017144) | 3.14765204 |
| 109 | cell differentiation involved in embryonic placenta development (GO:0060706) | 3.13428855 |
| 110 | bicarbonate transport (GO:0015701) | 3.12457428 |
| 111 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.12454999 |
| 112 | glucose 6-phosphate metabolic process (GO:0051156) | 3.11262123 |
| 113 | arachidonic acid secretion (GO:0050482) | 3.10893023 |
| 114 | icosanoid secretion (GO:0032309) | 3.10893023 |
| 115 | striated muscle atrophy (GO:0014891) | 3.09067083 |
| 116 | receptor recycling (GO:0001881) | 3.08956272 |
| 117 | positive regulation of digestive system process (GO:0060456) | 3.06284843 |
| 118 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.02431453 |
| 119 | lipoprotein transport (GO:0042953) | 3.01541418 |
| 120 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.00843294 |
| 121 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.00650437 |
| 122 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.99561374 |
| 123 | lipoprotein metabolic process (GO:0042157) | 2.98920142 |
| 124 | regulation of cholesterol homeostasis (GO:2000188) | 2.98258719 |
| 125 | fatty acid derivative transport (GO:1901571) | 2.97995525 |
| 126 | icosanoid transport (GO:0071715) | 2.97995525 |
| 127 | thrombin receptor signaling pathway (GO:0070493) | 2.97842340 |
| 128 | cellular ketone body metabolic process (GO:0046950) | 2.95735756 |
| 129 | benzene-containing compound metabolic process (GO:0042537) | 2.94255442 |
| 130 | fat-soluble vitamin metabolic process (GO:0006775) | 2.90622068 |
| 131 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.89629159 |
| 132 | rRNA catabolic process (GO:0016075) | 2.88471378 |
| 133 | positive regulation of epidermis development (GO:0045684) | 2.87567941 |
| 134 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.87464012 |
| 135 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.86205742 |
| 136 | detection of light stimulus involved in visual perception (GO:0050908) | 2.86205742 |
| 137 | diol metabolic process (GO:0034311) | 2.86069559 |
| 138 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.84007387 |
| 139 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.84007387 |
| 140 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.84007387 |
| 141 | oxidative demethylation (GO:0070989) | 2.83953576 |
| 142 | histone H3-K9 methylation (GO:0051567) | 2.83906024 |
| 143 | sperm capacitation (GO:0048240) | 2.83794270 |
| 144 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.83583689 |
| 145 | vitamin transmembrane transport (GO:0035461) | 2.83233331 |
| 146 | negative regulation of humoral immune response (GO:0002921) | 2.78914955 |
| 147 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.77148354 |
| 148 | cellular biogenic amine catabolic process (GO:0042402) | 2.76344181 |
| 149 | amine catabolic process (GO:0009310) | 2.76344181 |
| 150 | nucleus localization (GO:0051647) | 2.76321436 |
| 151 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.75215355 |
| 152 | cellular response to sterol (GO:0036315) | 2.74997740 |
| 153 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.74477308 |
| 154 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.74344032 |
| 155 | skeletal muscle adaptation (GO:0043501) | 2.73267669 |
| 156 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.73236133 |
| 157 | negative regulation of B cell mediated immunity (GO:0002713) | 2.73236133 |
| 158 | adhesion of symbiont to host (GO:0044406) | 2.73227234 |
| 159 | desmosome organization (GO:0002934) | 2.71898324 |
| 160 | amino acid transmembrane transport (GO:0003333) | 2.71300591 |
| 161 | negative regulation of telomerase activity (GO:0051974) | 2.71296799 |
| 162 | sphingoid metabolic process (GO:0046519) | 2.69835877 |
| 163 | phospholipid efflux (GO:0033700) | 2.69707137 |
| 164 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.67908588 |
| 165 | protein prenylation (GO:0018342) | 2.67900655 |
| 166 | prenylation (GO:0097354) | 2.67900655 |
| 167 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.65619101 |
| 168 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.65619101 |
| 169 | protein targeting to vacuole (GO:0006623) | 2.64587617 |
| 170 | protein targeting to lysosome (GO:0006622) | 2.64587617 |
| 171 | establishment of protein localization to vacuole (GO:0072666) | 2.64587617 |
| 172 | negative regulation of sodium ion transport (GO:0010766) | 2.63939877 |
| 173 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.63573860 |
| 174 | regulation of membrane lipid distribution (GO:0097035) | 2.63542124 |
| 175 | behavioral response to ethanol (GO:0048149) | 2.63050687 |
| 176 | aromatic amino acid family catabolic process (GO:0009074) | 2.61582780 |
| 177 | ketone body metabolic process (GO:1902224) | 2.59337240 |
| 178 | reflex (GO:0060004) | 2.57179265 |
| 179 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.56635041 |
| 180 | pericardium development (GO:0060039) | 2.56361891 |
| 181 | muscle atrophy (GO:0014889) | 2.55731444 |
| 182 | aromatic amino acid family metabolic process (GO:0009072) | 2.51817693 |
| 183 | serotonin metabolic process (GO:0042428) | 2.51770944 |
| 184 | histone H3-K9 modification (GO:0061647) | 2.51762009 |
| 185 | peptidyl-lysine trimethylation (GO:0018023) | 2.51701615 |
| 186 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.50963587 |
| 187 | histone lysine methylation (GO:0034968) | 2.49339061 |
| 188 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.49275619 |
| 189 | L-fucose catabolic process (GO:0042355) | 2.45749335 |
| 190 | fucose catabolic process (GO:0019317) | 2.45749335 |
| 191 | L-fucose metabolic process (GO:0042354) | 2.45749335 |
| 192 | regulation of skeletal muscle contraction (GO:0014819) | 2.42841309 |
| 193 | central nervous system neuron axonogenesis (GO:0021955) | 2.42726268 |
| 194 | auditory receptor cell stereocilium organization (GO:0060088) | 2.42502879 |
| 195 | alkaloid metabolic process (GO:0009820) | 2.42234878 |
| 196 | peptidyl-lysine methylation (GO:0018022) | 2.41495593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.57514833 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.21409603 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.39903075 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.39903075 |
| 5 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.39903075 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.98420338 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.19925618 |
| 8 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.09014461 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.73794772 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.72206221 |
| 11 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.71285405 |
| 12 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.67081430 |
| 13 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.65881879 |
| 14 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.51645639 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.50768495 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.40940622 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.38760441 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.35500524 |
| 19 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.34637716 |
| 20 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.33335989 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.31027330 |
| 22 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.30957155 |
| 23 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.29759944 |
| 24 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.27395440 |
| 25 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.23292580 |
| 26 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.20338571 |
| 27 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.19186582 |
| 28 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.18287830 |
| 29 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.17564992 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.16606564 |
| 31 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.12526144 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09859651 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.04872070 |
| 34 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 2.04330122 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.03480869 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02757184 |
| 37 | STAT3_23295773_ChIP-Seq_U87_Human | 2.02640244 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.01345777 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.01156426 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.95525346 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.95262532 |
| 42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.93666894 |
| 43 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.92837420 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.91186418 |
| 45 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88466006 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.86606366 |
| 47 | TP53_16413492_ChIP-PET_HCT116_Human | 1.85869395 |
| 48 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.85217128 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.84660298 |
| 50 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.83733475 |
| 51 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.78608675 |
| 52 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.77727653 |
| 53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77265020 |
| 54 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.76047297 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.74568924 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74241390 |
| 57 | TCF4_23295773_ChIP-Seq_U87_Human | 1.72664327 |
| 58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.72312523 |
| 59 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71164054 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.70793032 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.70656709 |
| 62 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.67063951 |
| 63 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66073859 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.64400414 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63536877 |
| 66 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.60408534 |
| 67 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.58853208 |
| 68 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.58853208 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58620415 |
| 70 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57627483 |
| 71 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.57445894 |
| 72 | EWS_26573619_Chip-Seq_HEK293_Human | 1.57379154 |
| 73 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.57033321 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.55575453 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52225852 |
| 76 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52225852 |
| 77 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.51984002 |
| 78 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.51390240 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.50497962 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.50465123 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50243006 |
| 82 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.50223107 |
| 83 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.49137249 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.47945051 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47720957 |
| 86 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47013862 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46462189 |
| 88 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.46035351 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.45540322 |
| 90 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.44990967 |
| 91 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.43917922 |
| 92 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.41922507 |
| 93 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.41484714 |
| 94 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.41377831 |
| 95 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.38414955 |
| 96 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36616191 |
| 97 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.36457651 |
| 98 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.35040679 |
| 99 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.34336431 |
| 100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33988983 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.33852040 |
| 102 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33221189 |
| 103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33202750 |
| 104 | ATF3_27146783_Chip-Seq_COLON_Human | 1.33131891 |
| 105 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.32875833 |
| 106 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.32151599 |
| 107 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.32148653 |
| 108 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.31419072 |
| 109 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30602237 |
| 110 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.30262240 |
| 111 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29941508 |
| 112 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29234148 |
| 113 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27910619 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 1.27669781 |
| 115 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27480967 |
| 116 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26682974 |
| 117 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24668554 |
| 118 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.23608090 |
| 119 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.23396409 |
| 120 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.23230223 |
| 121 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22803920 |
| 122 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22173744 |
| 123 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21919001 |
| 124 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21836556 |
| 125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21024166 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21024166 |
| 127 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19750480 |
| 128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.19695888 |
| 129 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.19290637 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18512440 |
| 131 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16816282 |
| 132 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16052521 |
| 133 | KDM2B_26808549_Chip-Seq_REH_Human | 1.13628980 |
| 134 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12731670 |
| 135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12722693 |
| 136 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.12722348 |
| 137 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.12489554 |
| 138 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11933496 |
| 139 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.11884615 |
| 140 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11454013 |
| 141 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11310909 |
| 142 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11161939 |
| 143 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10809833 |
| 144 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10809142 |
| 145 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.10612400 |
| 146 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09826821 |
| 147 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.08955593 |
| 148 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08563705 |
| 149 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08236012 |
| 150 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07145911 |
| 151 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06736454 |
| 152 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.06542922 |
| 153 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.06538241 |
| 154 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06396065 |
| 155 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06008107 |
| 156 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05430814 |
| 157 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05422362 |
| 158 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05410136 |
| 159 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04964069 |
| 160 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03906671 |
| 161 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03290960 |
| 162 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02751585 |
| 163 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.02553511 |
| 164 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02431458 |
| 165 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02395478 |
| 166 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.02216167 |
| 167 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98339132 |
| 168 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98124258 |
| 169 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98075361 |
| 170 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.96979074 |
| 171 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95829578 |
| 172 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.95685110 |
| 173 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94994663 |
| 174 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93849809 |
| 175 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.93071602 |
| 176 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92330283 |
| 177 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.89655492 |
| 178 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.88673645 |
| 179 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.88155247 |
| 180 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.88146323 |
| 181 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.87474770 |
| 182 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.87161880 |
| 183 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87128890 |
| 184 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.85477993 |
| 185 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83164773 |
| 186 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.81941250 |
| 187 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.80503957 |
| 188 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79969542 |
| 189 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79715930 |
| 190 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79507314 |
| 191 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.79152124 |
| 192 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.78925258 |
| 193 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78363698 |
| 194 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.77942487 |
| 195 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.76704540 |
| 196 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75639424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004264_abnormal_extraembryonic_tissu | 6.14825249 |
| 2 | MP0008057_abnormal_DNA_replication | 5.96041329 |
| 3 | MP0000569_abnormal_digit_pigmentation | 5.83345922 |
| 4 | MP0005360_urolithiasis | 5.08497022 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 4.71711546 |
| 6 | MP0001666_abnormal_nutrient_absorption | 4.29041320 |
| 7 | MP0003195_calcinosis | 3.85003595 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 3.44662488 |
| 9 | MP0003183_abnormal_peptide_metabolism | 3.34119531 |
| 10 | MP0000462_abnormal_digestive_system | 3.15404834 |
| 11 | MP0002254_reproductive_system_inflammat | 3.12031287 |
| 12 | MP0003866_abnormal_defecation | 3.06084229 |
| 13 | MP0003045_fibrosis | 2.93526388 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.91676831 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.73103956 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.66458499 |
| 17 | MP0000490_abnormal_crypts_of | 2.63057158 |
| 18 | MP0003646_muscle_fatigue | 2.59924714 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.34761095 |
| 20 | MP0003950_abnormal_plasma_membrane | 2.34292998 |
| 21 | MP0001873_stomach_inflammation | 2.24676286 |
| 22 | MP0002009_preneoplasia | 2.21254992 |
| 23 | * MP0010155_abnormal_intestine_physiology | 2.14639964 |
| 24 | MP0000477_abnormal_intestine_morphology | 2.11563729 |
| 25 | MP0004043_abnormal_pH_regulation | 2.10794756 |
| 26 | MP0002822_catalepsy | 2.09433423 |
| 27 | MP0000427_abnormal_hair_cycle | 2.07180263 |
| 28 | MP0001663_abnormal_digestive_system | 2.04360866 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 2.01968747 |
| 30 | MP0005381_digestive/alimentary_phenotyp | 1.97561858 |
| 31 | MP0002277_abnormal_respiratory_mucosa | 1.96882857 |
| 32 | MP0002168_other_aberrant_phenotype | 1.95912418 |
| 33 | MP0003252_abnormal_bile_duct | 1.92636804 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.88381426 |
| 35 | MP0004130_abnormal_muscle_cell | 1.85300086 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.82848388 |
| 37 | MP0003878_abnormal_ear_physiology | 1.82413768 |
| 38 | MP0005377_hearing/vestibular/ear_phenot | 1.82413768 |
| 39 | MP0001849_ear_inflammation | 1.82180979 |
| 40 | MP0000537_abnormal_urethra_morphology | 1.74184395 |
| 41 | MP0003011_delayed_dark_adaptation | 1.65977790 |
| 42 | MP0005365_abnormal_bile_salt | 1.65593051 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.63296471 |
| 44 | MP0009046_muscle_twitch | 1.62919977 |
| 45 | MP0004957_abnormal_blastocyst_morpholog | 1.62646048 |
| 46 | MP0005670_abnormal_white_adipose | 1.60392044 |
| 47 | MP0009840_abnormal_foam_cell | 1.60017185 |
| 48 | MP0001664_abnormal_digestion | 1.52772280 |
| 49 | MP0004858_abnormal_nervous_system | 1.47206033 |
| 50 | MP0002796_impaired_skin_barrier | 1.43978528 |
| 51 | MP0010678_abnormal_skin_adnexa | 1.39770490 |
| 52 | MP0003283_abnormal_digestive_organ | 1.38853044 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.38692395 |
| 54 | MP0002139_abnormal_hepatobiliary_system | 1.37232179 |
| 55 | MP0000230_abnormal_systemic_arterial | 1.31344391 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.29819061 |
| 57 | MP0003315_abnormal_perineum_morphology | 1.29368830 |
| 58 | MP0004484_altered_response_of | 1.28997578 |
| 59 | MP0001968_abnormal_touch/_nociception | 1.27583749 |
| 60 | MP0003890_abnormal_embryonic-extraembry | 1.25305299 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.24326967 |
| 62 | MP0002928_abnormal_bile_duct | 1.21929727 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.21210066 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.21019122 |
| 65 | MP0005310_abnormal_salivary_gland | 1.20889065 |
| 66 | MP0010386_abnormal_urinary_bladder | 1.19274601 |
| 67 | MP0006054_spinal_hemorrhage | 1.17653227 |
| 68 | MP0000371_diluted_coat_color | 1.17099441 |
| 69 | MP0002098_abnormal_vibrissa_morphology | 1.15196730 |
| 70 | MP0005395_other_phenotype | 1.14359152 |
| 71 | MP0004147_increased_porphyrin_level | 1.12751583 |
| 72 | MP0005499_abnormal_olfactory_system | 1.12627325 |
| 73 | MP0005394_taste/olfaction_phenotype | 1.12627325 |
| 74 | MP0000015_abnormal_ear_pigmentation | 1.10513099 |
| 75 | MP0003693_abnormal_embryo_hatching | 1.10323339 |
| 76 | MP0004381_abnormal_hair_follicle | 1.08826635 |
| 77 | MP0004019_abnormal_vitamin_homeostasis | 1.05392102 |
| 78 | MP0003879_abnormal_hair_cell | 1.04703242 |
| 79 | MP0002132_abnormal_respiratory_system | 1.04351697 |
| 80 | MP0005266_abnormal_metabolism | 1.04108144 |
| 81 | MP0001485_abnormal_pinna_reflex | 1.02443240 |
| 82 | MP0003724_increased_susceptibility_to | 1.01128437 |
| 83 | MP0009764_decreased_sensitivity_to | 1.00739534 |
| 84 | MP0003868_abnormal_feces_composition | 1.00609757 |
| 85 | MP0003633_abnormal_nervous_system | 0.99308198 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.97593534 |
| 87 | MP0005253_abnormal_eye_physiology | 0.97226791 |
| 88 | MP0005257_abnormal_intraocular_pressure | 0.95539588 |
| 89 | MP0000467_abnormal_esophagus_morphology | 0.93583720 |
| 90 | MP0004084_abnormal_cardiac_muscle | 0.93378936 |
| 91 | MP0008872_abnormal_physiological_respon | 0.93273736 |
| 92 | MP0000538_abnormal_urinary_bladder | 0.92613778 |
| 93 | MP0008877_abnormal_DNA_methylation | 0.91490574 |
| 94 | MP0003938_abnormal_ear_development | 0.91437680 |
| 95 | MP0001672_abnormal_embryogenesis/_devel | 0.90425065 |
| 96 | MP0005380_embryogenesis_phenotype | 0.90425065 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 0.89997909 |
| 98 | MP0002086_abnormal_extraembryonic_tissu | 0.89142518 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.88786247 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.88565054 |
| 101 | MP0005501_abnormal_skin_physiology | 0.87122380 |
| 102 | MP0008961_abnormal_basal_metabolism | 0.86403308 |
| 103 | MP0002166_altered_tumor_susceptibility | 0.86304265 |
| 104 | MP0003119_abnormal_digestive_system | 0.85966096 |
| 105 | MP0002088_abnormal_embryonic_growth/wei | 0.85703929 |
| 106 | MP0003984_embryonic_growth_retardation | 0.85450927 |
| 107 | MP0006082_CNS_inflammation | 0.85391374 |
| 108 | MP0001486_abnormal_startle_reflex | 0.84894296 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.84477720 |
| 110 | MP0000762_abnormal_tongue_morphology | 0.84178921 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.83788945 |
| 112 | MP0003191_abnormal_cellular_cholesterol | 0.83564415 |
| 113 | MP0006276_abnormal_autonomic_nervous | 0.83360277 |
| 114 | MP0001756_abnormal_urination | 0.83266186 |
| 115 | MP0005647_abnormal_sex_gland | 0.82751802 |
| 116 | MP0009745_abnormal_behavioral_response | 0.82283220 |
| 117 | MP0003631_nervous_system_phenotype | 0.81598247 |
| 118 | MP0003632_abnormal_nervous_system | 0.81490492 |
| 119 | MP0004036_abnormal_muscle_relaxation | 0.81400089 |
| 120 | MP0004145_abnormal_muscle_electrophysio | 0.80393963 |
| 121 | MP0001800_abnormal_humoral_immune | 0.79940427 |
| 122 | MP0005386_behavior/neurological_phenoty | 0.79715752 |
| 123 | MP0004924_abnormal_behavior | 0.79715752 |
| 124 | MP0004947_skin_inflammation | 0.79643529 |
| 125 | MP0000609_abnormal_liver_physiology | 0.78624890 |
| 126 | MP0003136_yellow_coat_color | 0.77895283 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.76979003 |
| 128 | MP0009643_abnormal_urine_homeostasis | 0.76617784 |
| 129 | MP0005023_abnormal_wound_healing | 0.76098153 |
| 130 | MP0001216_abnormal_epidermal_layer | 0.74650804 |
| 131 | MP0005448_abnormal_energy_balance | 0.74479441 |
| 132 | MP0008775_abnormal_heart_ventricle | 0.73566983 |
| 133 | MP0000377_abnormal_hair_follicle | 0.72393192 |
| 134 | MP0002229_neurodegeneration | 0.72229816 |
| 135 | MP0005397_hematopoietic_system_phenotyp | 0.71899605 |
| 136 | MP0001545_abnormal_hematopoietic_system | 0.71899605 |
| 137 | MP0001661_extended_life_span | 0.71664145 |
| 138 | MP0001986_abnormal_taste_sensitivity | 0.71591389 |
| 139 | MP0002735_abnormal_chemical_nociception | 0.71378537 |
| 140 | MP0003806_abnormal_nucleotide_metabolis | 0.71360414 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.70377024 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.69221512 |
| 143 | MP0003828_pulmonary_edema | 0.69178891 |
| 144 | MP0000383_abnormal_hair_follicle | 0.68985246 |
| 145 | MP0003943_abnormal_hepatobiliary_system | 0.67613253 |
| 146 | MP0005248_abnormal_Harderian_gland | 0.67161207 |
| 147 | MP0000350_abnormal_cell_proliferation | 0.66358619 |
| 148 | MP0001730_embryonic_growth_arrest | 0.65044961 |
| 149 | MP0003763_abnormal_thymus_physiology | 0.64797414 |
| 150 | MP0002067_abnormal_sensory_capabilities | 0.64315624 |
| 151 | MP0000613_abnormal_salivary_gland | 0.64106156 |
| 152 | MP0002396_abnormal_hematopoietic_system | 0.63793709 |
| 153 | MP0000516_abnormal_urinary_system | 0.63517378 |
| 154 | MP0005367_renal/urinary_system_phenotyp | 0.63517378 |
| 155 | MP0000465_gastrointestinal_hemorrhage | 0.63229898 |
| 156 | MP0002971_abnormal_brown_adipose | 0.62528439 |
| 157 | MP0003690_abnormal_glial_cell | 0.61552224 |
| 158 | MP0002736_abnormal_nociception_after | 0.61464993 |
| 159 | MP0002118_abnormal_lipid_homeostasis | 0.61096041 |
| 160 | MP0003941_abnormal_skin_development | 0.60412092 |
| 161 | MP0000470_abnormal_stomach_morphology | 0.59149163 |
| 162 | MP0006292_abnormal_olfactory_placode | 0.58125585 |
| 163 | MP0002653_abnormal_ependyma_morphology | 0.53927751 |
| 164 | MP0009115_abnormal_fat_cell | 0.52373245 |
| 165 | MP0002233_abnormal_nose_morphology | 0.51563493 |
| 166 | MP0002085_abnormal_embryonic_tissue | 0.51181206 |
| 167 | MP0000432_abnormal_head_morphology | 0.51067730 |
| 168 | MP0009384_cardiac_valve_regurgitation | 0.50858533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 7.25576363 |
| 2 | Genetic anticipation (HP:0003743) | 5.39111392 |
| 3 | Malnutrition (HP:0004395) | 5.36154563 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 4.82421443 |
| 5 | Bilateral microphthalmos (HP:0007633) | 4.67105506 |
| 6 | Gaze-evoked nystagmus (HP:0000640) | 4.63445032 |
| 7 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.39143721 |
| 8 | Abnormality of small intestinal villus morphology (HP:0011472) | 4.34016479 |
| 9 | Villous atrophy (HP:0011473) | 4.34016479 |
| 10 | Hyperventilation (HP:0002883) | 4.15318611 |
| 11 | Abdominal distention (HP:0003270) | 3.82584277 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.82353460 |
| 13 | Multiple enchondromatosis (HP:0005701) | 3.81424885 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.81319516 |
| 15 | Decreased circulating renin level (HP:0003351) | 3.77036788 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 3.62589602 |
| 17 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.61716471 |
| 18 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.54293159 |
| 19 | Clumsiness (HP:0002312) | 3.53112495 |
| 20 | Gastrointestinal dysmotility (HP:0002579) | 3.48196684 |
| 21 | Hepatoblastoma (HP:0002884) | 3.48001933 |
| 22 | Central scotoma (HP:0000603) | 3.47567549 |
| 23 | Dysmetric saccades (HP:0000641) | 3.46151348 |
| 24 | Acanthocytosis (HP:0001927) | 3.41849313 |
| 25 | Pancreatic cysts (HP:0001737) | 3.39354501 |
| 26 | Chronic diarrhea (HP:0002028) | 3.35980625 |
| 27 | Microretrognathia (HP:0000308) | 3.33770988 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.31470268 |
| 29 | Attenuation of retinal blood vessels (HP:0007843) | 3.29960331 |
| 30 | Fair hair (HP:0002286) | 3.29830536 |
| 31 | Chronic hepatic failure (HP:0100626) | 3.24720985 |
| 32 | Abnormal cartilage morphology (HP:0002763) | 3.19022244 |
| 33 | Flat acetabular roof (HP:0003180) | 3.11082505 |
| 34 | Protruding tongue (HP:0010808) | 3.04626985 |
| 35 | Micronodular cirrhosis (HP:0001413) | 3.02579010 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 3.01798161 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 3.01733878 |
| 38 | Abnormality of the renal cortex (HP:0011035) | 2.84715702 |
| 39 | Short humerus (HP:0005792) | 2.83098155 |
| 40 | Hyperactive renin-angiotensin system (HP:0000841) | 2.81404114 |
| 41 | Rib fusion (HP:0000902) | 2.81334851 |
| 42 | Febrile seizures (HP:0002373) | 2.81126979 |
| 43 | Ependymoma (HP:0002888) | 2.78158718 |
| 44 | Rectal prolapse (HP:0002035) | 2.76895518 |
| 45 | Abnormality of the lower motor neuron (HP:0002366) | 2.72980781 |
| 46 | Pancreatic fibrosis (HP:0100732) | 2.71159609 |
| 47 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.68223059 |
| 48 | Fat malabsorption (HP:0002630) | 2.67755547 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.67686619 |
| 50 | Facial diplegia (HP:0001349) | 2.67560989 |
| 51 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.66366667 |
| 52 | Cupped ribs (HP:0000887) | 2.65484394 |
| 53 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.63762376 |
| 54 | Combined immunodeficiency (HP:0005387) | 2.63198811 |
| 55 | Hypobetalipoproteinemia (HP:0003563) | 2.62994542 |
| 56 | Generalized hypopigmentation of hair (HP:0011358) | 2.62101151 |
| 57 | Cheilitis (HP:0100825) | 2.59593163 |
| 58 | Hyperkalemia (HP:0002153) | 2.58778995 |
| 59 | Abnormality of renin-angiotensin system (HP:0000847) | 2.58379054 |
| 60 | True hermaphroditism (HP:0010459) | 2.57834529 |
| 61 | Widely patent fontanelles and sutures (HP:0004492) | 2.57827869 |
| 62 | Partial duplication of thumb phalanx (HP:0009944) | 2.57463351 |
| 63 | Metabolic alkalosis (HP:0200114) | 2.54608087 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.49555246 |
| 65 | Trismus (HP:0000211) | 2.49405610 |
| 66 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.47901558 |
| 67 | Abnormal biliary tract morphology (HP:0012440) | 2.47327738 |
| 68 | Curly hair (HP:0002212) | 2.43389628 |
| 69 | Dehydration (HP:0001944) | 2.42709717 |
| 70 | Stomach cancer (HP:0012126) | 2.42380469 |
| 71 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.41988452 |
| 72 | Increased connective tissue (HP:0009025) | 2.39857133 |
| 73 | Scotoma (HP:0000575) | 2.35857317 |
| 74 | Cystic liver disease (HP:0006706) | 2.33481165 |
| 75 | Thyroid-stimulating hormone excess (HP:0002925) | 2.33468339 |
| 76 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.31743696 |
| 77 | Abnormality of the salivary glands (HP:0010286) | 2.31588463 |
| 78 | Tongue fasciculations (HP:0001308) | 2.31513857 |
| 79 | Abnormality of proline metabolism (HP:0010907) | 2.30694623 |
| 80 | Hydroxyprolinuria (HP:0003080) | 2.30694623 |
| 81 | Hyperglycinuria (HP:0003108) | 2.29344701 |
| 82 | Abnormality of the 1st metacarpal (HP:0010009) | 2.28454976 |
| 83 | Abnormality of chloride homeostasis (HP:0011422) | 2.25841803 |
| 84 | Ventricular tachycardia (HP:0004756) | 2.25327496 |
| 85 | Widely spaced teeth (HP:0000687) | 2.24586001 |
| 86 | Abnormality of the renal medulla (HP:0100957) | 2.23902744 |
| 87 | Shawl scrotum (HP:0000049) | 2.22600428 |
| 88 | Impulsivity (HP:0100710) | 2.19796674 |
| 89 | Tubular atrophy (HP:0000092) | 2.18540560 |
| 90 | Enlarged kidneys (HP:0000105) | 2.18323519 |
| 91 | Cerebellar dysplasia (HP:0007033) | 2.18190551 |
| 92 | Absent speech (HP:0001344) | 2.17666616 |
| 93 | Abnormality of potassium homeostasis (HP:0011042) | 2.17514139 |
| 94 | Ragged-red muscle fibers (HP:0003200) | 2.16249931 |
| 95 | Fused cervical vertebrae (HP:0002949) | 2.15173698 |
| 96 | Partial duplication of the phalanx of hand (HP:0009999) | 2.14716566 |
| 97 | Woolly hair (HP:0002224) | 2.12213471 |
| 98 | Pili torti (HP:0003777) | 2.08909601 |
| 99 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.07942084 |
| 100 | Rhabdomyosarcoma (HP:0002859) | 2.07399471 |
| 101 | Abnormal albumin level (HP:0012116) | 2.07342523 |
| 102 | Hypoalbuminemia (HP:0003073) | 2.07342523 |
| 103 | Congenital stationary night blindness (HP:0007642) | 2.07188007 |
| 104 | Dialeptic seizures (HP:0011146) | 2.07097385 |
| 105 | Broad-based gait (HP:0002136) | 2.06813717 |
| 106 | Muscle fibrillation (HP:0010546) | 2.06190553 |
| 107 | Biliary tract neoplasm (HP:0100574) | 2.04678258 |
| 108 | Testicular atrophy (HP:0000029) | 2.04550611 |
| 109 | Hyperaldosteronism (HP:0000859) | 2.02926374 |
| 110 | Large earlobe (HP:0009748) | 2.02456821 |
| 111 | Neoplasm of striated muscle (HP:0009728) | 2.02330781 |
| 112 | Abnormality of the nasal septum (HP:0000419) | 2.01405591 |
| 113 | Tubulointerstitial nephritis (HP:0001970) | 2.00500406 |
| 114 | Postural instability (HP:0002172) | 1.98199105 |
| 115 | Autoimmune hemolytic anemia (HP:0001890) | 1.95900218 |
| 116 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.95167521 |
| 117 | Gastrointestinal carcinoma (HP:0002672) | 1.95167521 |
| 118 | Astrocytoma (HP:0009592) | 1.94861772 |
| 119 | Abnormality of the astrocytes (HP:0100707) | 1.94861772 |
| 120 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.94825392 |
| 121 | Portal hypertension (HP:0001409) | 1.94485961 |
| 122 | Preaxial foot polydactyly (HP:0001841) | 1.90927203 |
| 123 | Congenital sensorineural hearing impairment (HP:0008527) | 1.90571240 |
| 124 | Intrahepatic cholestasis (HP:0001406) | 1.90475913 |
| 125 | Focal seizures (HP:0007359) | 1.90237143 |
| 126 | Uterine neoplasm (HP:0010784) | 1.88001042 |
| 127 | Abnormality of midbrain morphology (HP:0002418) | 1.86599931 |
| 128 | Molar tooth sign on MRI (HP:0002419) | 1.86599931 |
| 129 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.85849569 |
| 130 | Abnormality of the fingertips (HP:0001211) | 1.85669951 |
| 131 | Blue irides (HP:0000635) | 1.84850449 |
| 132 | Abnormality of the hepatic vasculature (HP:0006707) | 1.84434841 |
| 133 | Nephronophthisis (HP:0000090) | 1.83312175 |
| 134 | Congenital hepatic fibrosis (HP:0002612) | 1.83098948 |
| 135 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.82752349 |
| 136 | Absence seizures (HP:0002121) | 1.82560903 |
| 137 | Tetraplegia (HP:0002445) | 1.82158220 |
| 138 | Hypokalemia (HP:0002900) | 1.81271386 |
| 139 | Petechiae (HP:0000967) | 1.81049377 |
| 140 | Hypoplastic labia majora (HP:0000059) | 1.80098739 |
| 141 | Hematochezia (HP:0002573) | 1.79923107 |
| 142 | Truncal obesity (HP:0001956) | 1.79547422 |
| 143 | Hypoplastic scapulae (HP:0000882) | 1.78495834 |
| 144 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.78495834 |
| 145 | Abnormality of carpal bone ossification (HP:0006257) | 1.78309079 |
| 146 | Tracheal stenosis (HP:0002777) | 1.77849100 |
| 147 | Abnormality of vitamin metabolism (HP:0100508) | 1.77575760 |
| 148 | Milia (HP:0001056) | 1.77408336 |
| 149 | Abnormality of the labia majora (HP:0012881) | 1.77337165 |
| 150 | Ventricular fibrillation (HP:0001663) | 1.76980053 |
| 151 | Pigmentary retinal degeneration (HP:0001146) | 1.75483391 |
| 152 | Clubbing of toes (HP:0100760) | 1.75438914 |
| 153 | Abolished electroretinogram (ERG) (HP:0000550) | 1.75404200 |
| 154 | Sandal gap (HP:0001852) | 1.74752926 |
| 155 | Submucous cleft hard palate (HP:0000176) | 1.74439793 |
| 156 | Progressive inability to walk (HP:0002505) | 1.74362871 |
| 157 | Abnormality of vitamin B metabolism (HP:0004340) | 1.74116451 |
| 158 | Short chin (HP:0000331) | 1.73891483 |
| 159 | Renal cortical cysts (HP:0000803) | 1.73682717 |
| 160 | Acute myeloid leukemia (HP:0004808) | 1.73024862 |
| 161 | Periauricular skin pits (HP:0100277) | 1.72818826 |
| 162 | Preauricular pit (HP:0004467) | 1.72818826 |
| 163 | Hand muscle atrophy (HP:0009130) | 1.72652886 |
| 164 | Hyperparathyroidism (HP:0000843) | 1.72467601 |
| 165 | Abnormal drinking behavior (HP:0030082) | 1.72309497 |
| 166 | Polydipsia (HP:0001959) | 1.72309497 |
| 167 | Fasciculations (HP:0002380) | 1.71618832 |
| 168 | Abnormality of the gastric mucosa (HP:0004295) | 1.71500456 |
| 169 | Keratoconus (HP:0000563) | 1.71337566 |
| 170 | Increased corneal curvature (HP:0100692) | 1.71337566 |
| 171 | Horizontal nystagmus (HP:0000666) | 1.70215464 |
| 172 | Rectovaginal fistula (HP:0000143) | 1.70170620 |
| 173 | Rectal fistula (HP:0100590) | 1.70170620 |
| 174 | Intestinal fistula (HP:0100819) | 1.70030591 |
| 175 | Furrowed tongue (HP:0000221) | 1.68344939 |
| 176 | Cupped ear (HP:0000378) | 1.67650385 |
| 177 | Inability to walk (HP:0002540) | 1.67379577 |
| 178 | Abnormal ciliary motility (HP:0012262) | 1.66145134 |
| 179 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.65054879 |
| 180 | Medial flaring of the eyebrow (HP:0010747) | 1.64628951 |
| 181 | Hip dysplasia (HP:0001385) | 1.63610343 |
| 182 | Macular degeneration (HP:0000608) | 1.63331397 |
| 183 | Hypopigmentation of the fundus (HP:0007894) | 1.63181005 |
| 184 | Abnormality of the ischium (HP:0003174) | 1.62719938 |
| 185 | Chromsome breakage (HP:0040012) | 1.62670869 |
| 186 | Poor coordination (HP:0002370) | 1.62562322 |
| 187 | Tubulointerstitial abnormality (HP:0001969) | 1.62421420 |
| 188 | Progressive visual loss (HP:0000529) | 1.61642515 |
| 189 | Amelogenesis imperfecta (HP:0000705) | 1.61527170 |
| 190 | Increased density of long bones (HP:0006392) | 1.61367508 |
| 191 | Spastic paraplegia (HP:0001258) | 1.60700233 |
| 192 | Hyperalaninemia (HP:0003348) | 1.59880938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 5.43969923 |
| 2 | LMTK2 | 4.78871390 |
| 3 | FRK | 4.73091361 |
| 4 | GRK6 | 4.60229113 |
| 5 | ACVR1B | 4.28871609 |
| 6 | MST4 | 3.76494187 |
| 7 | ERN1 | 3.43919947 |
| 8 | PRKG2 | 3.33450047 |
| 9 | GRK5 | 2.90616847 |
| 10 | BMPR1B | 2.79570935 |
| 11 | GRK1 | 2.54010472 |
| 12 | MST1R | 2.46384385 |
| 13 | TTK | 2.39511491 |
| 14 | STK10 | 2.30315064 |
| 15 | EPHA2 | 2.22815234 |
| 16 | AKT3 | 2.10984895 |
| 17 | MATK | 2.10333326 |
| 18 | MAP3K10 | 2.05863367 |
| 19 | PIK3CG | 2.03259124 |
| 20 | BRD4 | 1.75068014 |
| 21 | RIPK1 | 1.67392619 |
| 22 | MAP2K2 | 1.64661275 |
| 23 | NME1 | 1.60878008 |
| 24 | BLK | 1.58557220 |
| 25 | ADRBK2 | 1.52489571 |
| 26 | TYRO3 | 1.47542722 |
| 27 | CAMK1D | 1.43665894 |
| 28 | CAMK1G | 1.39367815 |
| 29 | CSF1R | 1.37083099 |
| 30 | MKNK2 | 1.36066064 |
| 31 | PAK4 | 1.33288380 |
| 32 | INSRR | 1.27157378 |
| 33 | STK38L | 1.23365625 |
| 34 | TEC | 1.23057897 |
| 35 | TGFBR2 | 1.21999708 |
| 36 | PTK6 | 1.20408064 |
| 37 | CAMKK2 | 1.20022351 |
| 38 | NLK | 1.19600414 |
| 39 | SGK2 | 1.18800433 |
| 40 | TESK1 | 1.14703459 |
| 41 | MAP2K6 | 1.10588573 |
| 42 | PRKCI | 1.10043266 |
| 43 | MYLK | 1.06200816 |
| 44 | LATS1 | 1.05934545 |
| 45 | NTRK3 | 1.03889834 |
| 46 | TRPM7 | 1.02875625 |
| 47 | MAPK7 | 1.01433280 |
| 48 | MAP3K2 | 1.00874850 |
| 49 | MAP3K7 | 0.93922314 |
| 50 | STK39 | 0.92918115 |
| 51 | WNK3 | 0.92740920 |
| 52 | EPHB2 | 0.92009226 |
| 53 | ERBB2 | 0.91753147 |
| 54 | IRAK1 | 0.91651411 |
| 55 | WNK1 | 0.90974083 |
| 56 | CDK7 | 0.90556143 |
| 57 | PTK2 | 0.87973382 |
| 58 | MET | 0.87417072 |
| 59 | NUAK1 | 0.86488367 |
| 60 | GRK7 | 0.85183787 |
| 61 | PIK3CA | 0.85053727 |
| 62 | STK38 | 0.84831648 |
| 63 | ZAK | 0.84346793 |
| 64 | TNK2 | 0.83001033 |
| 65 | MAPK13 | 0.82434463 |
| 66 | BRSK2 | 0.82162145 |
| 67 | TGFBR1 | 0.79982715 |
| 68 | MOS | 0.76559616 |
| 69 | MAP3K4 | 0.74322654 |
| 70 | TAOK1 | 0.73660651 |
| 71 | DDR2 | 0.72049861 |
| 72 | MAP3K8 | 0.70777585 |
| 73 | PTK2B | 0.70666771 |
| 74 | CHEK2 | 0.68545380 |
| 75 | KIT | 0.67241480 |
| 76 | MAP4K2 | 0.65737351 |
| 77 | CSK | 0.65410516 |
| 78 | AURKB | 0.65047033 |
| 79 | TESK2 | 0.64209953 |
| 80 | DAPK2 | 0.63726212 |
| 81 | SGK494 | 0.63332742 |
| 82 | SGK223 | 0.63332742 |
| 83 | RPS6KB2 | 0.61916610 |
| 84 | FGFR3 | 0.60122676 |
| 85 | OBSCN | 0.59953714 |
| 86 | AKT2 | 0.59854344 |
| 87 | ITK | 0.59704577 |
| 88 | BTK | 0.59508800 |
| 89 | NTRK1 | 0.59452705 |
| 90 | CAMK4 | 0.58467377 |
| 91 | EEF2K | 0.58163098 |
| 92 | JAK1 | 0.56882233 |
| 93 | TXK | 0.56178496 |
| 94 | SGK3 | 0.54656970 |
| 95 | PRKAA2 | 0.53595434 |
| 96 | SGK1 | 0.52645764 |
| 97 | EPHA3 | 0.52499936 |
| 98 | ADRBK1 | 0.51529754 |
| 99 | PRKCE | 0.51236821 |
| 100 | PRKAA1 | 0.51223967 |
| 101 | SYK | 0.49974500 |
| 102 | SCYL2 | 0.48969315 |
| 103 | STK3 | 0.48786973 |
| 104 | TNIK | 0.48620412 |
| 105 | STK11 | 0.48424092 |
| 106 | BMX | 0.47797835 |
| 107 | CASK | 0.47592893 |
| 108 | CHUK | 0.47115445 |
| 109 | MARK2 | 0.46966997 |
| 110 | OXSR1 | 0.46071902 |
| 111 | MKNK1 | 0.45278699 |
| 112 | MARK3 | 0.44847102 |
| 113 | WNK4 | 0.44840504 |
| 114 | PAK1 | 0.44398347 |
| 115 | PLK1 | 0.43574800 |
| 116 | KSR2 | 0.42543189 |
| 117 | FGFR2 | 0.42398280 |
| 118 | MAP3K9 | 0.42153014 |
| 119 | PINK1 | 0.40583784 |
| 120 | HCK | 0.39969073 |
| 121 | PDK2 | 0.39225486 |
| 122 | PDGFRB | 0.38351308 |
| 123 | RET | 0.38130629 |
| 124 | CAMK1 | 0.37668836 |
| 125 | JAK2 | 0.37169597 |
| 126 | IKBKE | 0.34928758 |
| 127 | NEK6 | 0.34700125 |
| 128 | ALK | 0.34023852 |
| 129 | IKBKB | 0.34021385 |
| 130 | LYN | 0.33534013 |
| 131 | PDGFRA | 0.33463955 |
| 132 | PDPK1 | 0.32556905 |
| 133 | FES | 0.32375065 |
| 134 | PAK2 | 0.31900400 |
| 135 | MAPK11 | 0.31716403 |
| 136 | LCK | 0.31687507 |
| 137 | DYRK1A | 0.31686706 |
| 138 | FER | 0.30782103 |
| 139 | MELK | 0.30193567 |
| 140 | MAP2K1 | 0.28969670 |
| 141 | DMPK | 0.28175145 |
| 142 | MAPKAPK2 | 0.27799567 |
| 143 | FLT3 | 0.27698743 |
| 144 | PRKACB | 0.26739509 |
| 145 | MAP3K3 | 0.26703783 |
| 146 | MAPKAPK3 | 0.26596278 |
| 147 | PKN2 | 0.26418321 |
| 148 | CHEK1 | 0.25967574 |
| 149 | MAP3K14 | 0.25554239 |
| 150 | MAPK1 | 0.25218965 |
| 151 | PAK3 | 0.25167494 |
| 152 | CAMK2A | 0.25073001 |
| 153 | EPHA4 | 0.24966877 |
| 154 | NEK2 | 0.24537019 |
| 155 | ICK | 0.24189656 |
| 156 | HIPK2 | 0.23685535 |
| 157 | PRKCD | 0.22537025 |
| 158 | LRRK2 | 0.22112294 |
| 159 | CSNK1E | 0.21985386 |
| 160 | PDK1 | 0.21489313 |
| 161 | DYRK1B | 0.21438266 |
| 162 | MTOR | 0.20972856 |
| 163 | PRKACG | 0.20259033 |
| 164 | GSK3A | 0.19945107 |
| 165 | SRC | 0.19261181 |
| 166 | TAOK3 | 0.18424006 |
| 167 | IGF1R | 0.18067907 |
| 168 | LIMK1 | 0.16898954 |
| 169 | CSNK1A1 | 0.13695528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.45952025 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.34839725 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 3.83631066 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.72935081 |
| 5 | Galactose metabolism_Homo sapiens_hsa00052 | 3.52306670 |
| 6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.50831153 |
| 7 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.47339371 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.64185291 |
| 9 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.54694393 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.53105005 |
| 11 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.33114367 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.26049667 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 2.20011611 |
| 14 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.04193519 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.02479862 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.00202515 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94293773 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94003684 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.83675862 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.82562977 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.81287119 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.79017707 |
| 23 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.75247563 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63552056 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.61597703 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.61066860 |
| 27 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.58222636 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.55603949 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.46160425 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42199565 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.39406655 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.37665756 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.35584013 |
| 34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30304960 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.26783308 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.26560541 |
| 37 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.15543074 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15352009 |
| 39 | Thyroid cancer_Homo sapiens_hsa05216 | 1.15042140 |
| 40 | Tight junction_Homo sapiens_hsa04530 | 1.14100844 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.13516769 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11449441 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.08948130 |
| 44 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.07694155 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.04798344 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.00914951 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97786345 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97276684 |
| 49 | Nicotine addiction_Homo sapiens_hsa05033 | 0.96315927 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94251964 |
| 51 | Morphine addiction_Homo sapiens_hsa05032 | 0.92512903 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 0.90303236 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88980010 |
| 54 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88474323 |
| 55 | Homologous recombination_Homo sapiens_hsa03440 | 0.88402304 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87938612 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86729878 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.86425263 |
| 59 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86383690 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86322223 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.85932991 |
| 62 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.83784314 |
| 63 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79438328 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77900279 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77723268 |
| 66 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76430595 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76346615 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.74838811 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72432166 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72367759 |
| 71 | Long-term depression_Homo sapiens_hsa04730 | 0.71319281 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.69949778 |
| 73 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69920304 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68352009 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68288247 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67469174 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67009013 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66073096 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63896162 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63385447 |
| 81 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63378725 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.63137110 |
| 83 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62852286 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61911178 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.61531849 |
| 86 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61149550 |
| 87 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60568522 |
| 88 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60092635 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60037930 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59407784 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58367717 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55080528 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54246002 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.52673312 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51683650 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50549459 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50373838 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49916036 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49261479 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.47440669 |
| 101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47191592 |
| 102 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.46824312 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46072120 |
| 104 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.45820567 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44811052 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43736449 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42231832 |
| 108 | GABAergic synapse_Homo sapiens_hsa04727 | 0.40449392 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39727946 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39628018 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39301776 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39231942 |
| 113 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38384814 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38062020 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37990577 |
| 116 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37763001 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37063892 |
| 118 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.36548116 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33341387 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30927140 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30674091 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30632267 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29678126 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28976293 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.26895635 |
| 126 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26830967 |
| 127 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.25691105 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.24931660 |
| 129 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24573593 |
| 130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.24508264 |
| 131 | Lysine degradation_Homo sapiens_hsa00310 | 0.22890799 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22836412 |
| 133 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22632737 |
| 134 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22450464 |
| 135 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20482811 |
| 136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.18748002 |
| 137 | Salivary secretion_Homo sapiens_hsa04970 | 0.17574935 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.17573717 |
| 139 | Apoptosis_Homo sapiens_hsa04210 | 0.15256910 |
| 140 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.14528625 |
| 141 | Influenza A_Homo sapiens_hsa05164 | 0.14161299 |
| 142 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14057375 |
| 143 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13911448 |
| 144 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.13237354 |
| 145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13164378 |
| 146 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.12836103 |
| 147 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12116308 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10916087 |

